Shots:
- Pierre Fabre Laboratories has entered into an integrated drug discovery collaboration with Iktos to identify & develop novel small-molecule drug candidates in oncology
- As per the deal, Iktos will apply its AI-driven generative design platform to rapidly identify optimized small-molecule candidates for an undisclosed oncology target, while Pierre Fabre will contribute oncology & preclinical expertise to guide candidate selection, evaluation, & advancement
- The financial terms were not disclosed, though the agreement includes an upfront payment along with multiple milestone-based payments
Ref: PRnewswire | Image: Pierre Fabre & Iktos | Press Release
PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com
